Details of the Drug Formulations

General Information of Drug (ID: DMHG57U)

Drug Name
OPC-34712 Drug Info
Synonyms Brexpiprazole
Indication
Disease Entry ICD 11 Status REF
Major depressive disorder 6A70.3 Approved [1]
Cross-matching ID
PubChem CID
11978813
ChEBI ID
CHEBI:134716
CAS Number
913611-97-9
TTD ID
D0P0OU
VARIDT ID
DR01335
INTEDE ID
DR0227
ACDINA ID
D00076

Full List of Drug Formulations Containing This Drug

Brexpiprazole 0.25 mg tablet
Company Formulation ID FDA Description
Otsuka America Pharmaceutical F02703 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Brexpiprazole 0.5 mg tablet
Company Formulation ID FDA Description
Otsuka America Pharmaceutical F02704 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Brexpiprazole 2 mg tablet
Company Formulation ID FDA Description
Otsuka America Pharmaceutical F02706 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Brexpiprazole 3 mg tablet
Company Formulation ID FDA Description
Otsuka America Pharmaceutical F02707 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferrosoferric oxide; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Brexpiprazole 1 mg tablet
Company Formulation ID FDA Description
Avera McKennan Hospital; Otsuka America Pharmaceutical F02705 Lactose monohydrate; Magnesium stearate; Ferric oxide yellow; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------
Brexpiprazole 4 mg tablet
Company Formulation ID FDA Description
Otsuka America Pharmaceutical F02708 Lactose monohydrate; Magnesium stearate; Talc; Titanium dioxide; Hydroxypropyl cellulose (1200000 mw); Hypromellose, unspecified; Low-substituted hydroxypropyl cellulose, unspecified; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7672).